Last reviewed · How we verify
NCT05958966
Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2
NA trial testing E-cigarette e-liquid self-administration in Electronic Cigarette Use in 73 participants. Completed in 1 May 2023.
1 May 2023
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | other |
| Enrollment | 73 |
| Start date | 1 April 2022 |
| Primary completion | 1 May 2023 |
| Estimated completion | 1 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- E-cigarette e-liquid self-administration
Conditions studied
- Electronic Cigarette Use — all drugs for Electronic Cigarette Use →
- E-Cig Use — all drugs for E-Cig Use →
- Cigarette Smoking — all drugs for Cigarette Smoking →
- Cigarette Use, Electronic — all drugs for Cigarette Use, Electronic →
Sponsor
University of Southern California
Who can join
21 and older, any sex, with Electronic Cigarette Use or E-Cig Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For this substudy, adult smokers (N=200) will attend two laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, nicotine formulation) and smoke their own cigarettes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05958966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Electronic Cigarette Use
Currently open trials in the same condition.
- NCT06609109 — Effect of Cannabis on E-Cigarette Use Behavior · Phase 1 · recruiting
- NCT06610838 — Effects of E-cigarette Use on Health · recruiting
- NCT04907136 — Developing and Testing Health Warning Labels on the ENDS Device · NA · recruiting
- NCT06142877 — Effects of Social Media Use on Young Adults' E-Cigarette Use · NA · recruiting
- NCT05338801 — Effect of Menthol on ENDS Users' Addiction and Exposure · NA · recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05958966 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 25 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05958966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing